This compares to loss of $0.28 per share a. Agenus (nasdaq:agen) last posted its quarterly earnings data on sunday, august 8th.
Moreover, agen currently has a zacks rank #2 (buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and eps surprises.
Agen stock forecast zacks. The zacks momentum style score encompasses many things, including estimate revisions and a stock's price movement. Agenus (agen) came out with a quarterly loss of $0.20 per share versus the zacks consensus estimate of a loss of $0.22. 24, 2021 at 10:00 a.m.
Equities research analysts forecast that agenus inc. Three analysts surveyed by zacks expected $183.1 million. Want the latest recommendations from zacks investment research?
Agenus (agen) came out with a quarterly loss of $0.37 per share versus the zacks consensus estimate of a loss of $0.24. Equities research analysts forecast that agenus inc. The biotechnology company posted revenue of $253 million in the period, also exceeding street forecasts.
A year ago, they were. Agenus (agen) came out with quarterly earnings of $0.69 per share, beating the zacks consensus estimate of $0.46 per share. Click to get this free report agenus inc.
Three analysts have provided estimates for agenus earnings, with the highest eps estimate coming in at ($0.04) and the lowest estimate coming in at ($0.16). This suggests a possible upside of 263.0% from the stock's current price. Zacks' proprietary data indicates that agenus inc.
Their forecasts range from $11.00 to $11.00. Right now, agen is averaging 2,598,550 shares for the last 20 days. 26, 2021 at 10:00 a.m.
This compares to loss of $0.22 per share a year ago. This compares to loss of $0.28 per share a year. Get the latest gamida cell ltd.
On average, they anticipate agenus' share price to reach $11.00 in the next year. For the next fiscal year, analysts forecast that the company will post sales of $99.27 million, with estimates ranging from $69.80 million to $143.20 million. Zacks' sales averages are a mean average based on a survey of research analysts that cover agenus.
This page was last updated on 12/6/2021 by marketbeat.com staff. The average estimate of three analysts surveyed by zacks investment research was for earnings of 46 cents per share. Today, you can download 7 best stocks for the next 30 days.
The company's shares closed at $4.18. Et on zacks.com are atea pharmaceuticals, agenus, novavax, and ocular therapeutix bad news buy? This compares to loss of $0.28 per share a year ago.
(nasdaq:agen) will announce ($0.12) earnings per share for the current fiscal quarter, zacks reports. Gmda investment & stock information. (nasdaq:agen) will announce ($0.12) earnings per share for the current fiscal quarter, zacks reports.
Insiders have sold a total of 875,127 agenus shares in the last 24 months for a total of $3,453,393.50 sold. Three analysts have provided estimates for agenus earnings, with the highest eps estimate coming in at ($0.04) and the lowest estimate coming in at ($0.16). Is currently rated as a zacks rank 3 and we are expecting an inline return from the agen.
Agenus (agen) came out with quarterly earnings of $0.69 per share, beating the zacks consensus estimate of $0.46 per share.
0 komentar:
Posting Komentar